Bacterial Infections
RSSArticles
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Study: Long-Term Use of Clopidogrel for DES Patients
Drug Labels A Prescription for Misunderstanding?; Beta-Blockers and Depression Unlinked?; FDA Actions -
Updates: Long-Term Care Facilities and VRE; Gay Men and Occult GC
-
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch: HRT - Position Paper Places Benefits in Question
-
Updates: Antiretroviral Therapy and Pregnancy; Cryptococcosis on Vancouver Island; Foodborne Outbreaks
-
Parvovirus B19 Transmissions During Thoracic Surgery from a Pooled Plasma Product
-
Updates: Mosquitoes and Patients with HIV; Pneumococcal Vaccination in SLE and RA; Highly Resistant GC Marches Toward U.S.
-
CD4 Lymphocyte Percentage and HIV Disease Progression
This study out of Vanderbilt examined a cohort of 788 eligible patients from their clinic who received their first highly active antiretroviral therapy (HAART) regimen for at least 30 days between January 1998 and January 2003 and had a baseline CD4 lymphocyte determination in the 180 days prior to initiating antiretrovirals or within 45 of starting treatment. -
Methods for Diagnosing Intravascular Device-Related Bloodstream Infections — And the Winner Is?
There exists no consensus about the best means for diagnosing bloodstream infections related to intravascular devices (IVD), leading Safdar and colleagues to conduct a formal meta-analysis using the data supplied by 51 of the 185 studies published between 1966 and July 31, 2004, that met the selection criteria.